Eli Lilly and Company's Fiscal Year is From January To December.
The item "Receivables-Turnover" stands at 3.72 as of 09/30/2025.
As of the end of Eli Lilly and Company's third quarter, the item "Receivables Turnover" stands at 3.72. This represents a decrease of -1.35 percent compared to it's value at the end of it's second quarter .
Regarding the One-Year-Change of the series, the current value constitutes an increase of 5.70 percent compared to the value the year prior.
The 1 year change in percent is 5.70.
The 3 year change in percent is 1.48.
| Logo | Name | Market Cap (USD) |
|---|---|---|
![]() | Johnson & Johnson - Receivables Turnover | 486,508,953,600.00 |
![]() | AbbVie Inc - Receivables Turnover | 399,570,305,024.00 |
![]() | Roche Holding AG - Receivables Turnover | 317,433,206,677.55 |
![]() | AstraZeneca PLC - Receivables Turnover | 280,205,508,085.11 |
![]() | Novartis AG - Receivables Turnover | 255,096,620,580.91 |